Bio Green Med Solution (BGMS) Profit After Tax (QoQ) (2010 - 2026)
Powered by 
Analysis
Bio Green Med Solution (BGMS) Profit After Tax (QoQ) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.26 Bn | 133.41 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 87.03 Bn | 79.04 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.00 Bn | 59.81 Bn | 1.37 Bn |
| 4 | Moderna | 57.92 Bn | 52.78 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.18 Bn | 44.18 Bn | - |
| 6 | BeOne Medicines | 40.32 Bn | 35.22 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.02 Bn | 27.19 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Bio Green Med Solution | 5.04 Mn | 1.25 Mn | 79,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -105.58% |
| Mar 31, 2026 | 98.28% |
| Dec 31, 2025 | -1,035.05% |
| Sep 30, 2025 | 23.60% |
| Jun 30, 2025 | -1,527.16% |
| Mar 31, 2025 | 98.42% |
| Dec 31, 2024 | -161.57% |
| Sep 30, 2024 | 39.91% |
| Jun 30, 2024 | -10.56% |
| Mar 31, 2024 | 44.63% |
| Dec 31, 2023 | 12.51% |
| Sep 30, 2023 | -11.64% |
| Jun 30, 2023 | 6.13% |
| Mar 31, 2023 | 22.29% |
| Dec 31, 2022 | -45.14% |
| Sep 30, 2022 | -12.48% |
| Jun 30, 2022 | -11.37% |
| Mar 31, 2022 | 22.42% |
| Dec 31, 2021 | -11.31% |
| Sep 30, 2021 | 7.22% |